Kevin Litchfield
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Co-authors
- Charles SwantonClare TurnbullSamra TurajlicRoberto VendraminRichard S. HoulstonSergio A. QuezadaJames L. ReadingJames Larkin
- Topics
- Cancer Immunotherapy and Biomarkers (18 papers)Cancer Genomics and Diagnostics (16 papers)Testicular diseases and treatments (14 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Kevin Litchfield
48 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 900
- Oncology 885
- Cancer Research 585
- Pulmonary and Respiratory Medicine 509
- Immunology 458
Countries citing papers authored by Kevin Litchfield
This map shows the geographic impact of Kevin Litchfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Litchfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Litchfield more than expected).
Fields of papers citing papers by Kevin Litchfield
This network shows the impact of papers produced by Kevin Litchfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Litchfield. The network helps show where Kevin Litchfield may publish in the future.
Co-authorship network of co-authors of Kevin Litchfield
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Litchfield. A scholar is included among the top collaborators of Kevin Litchfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Litchfield. Kevin Litchfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 8 | |
| 3 | 15 | |
| 4 | 16 | |
| 5 | 30 | |
| 6 | 40 | |
| 7 | 36 | |
| 8 | 0 | |
| 9 | 0 | |
| 10 | 12 | |
| 11 | 30 | |
| 12 | 9 | |
| 13 | 14 | |
| 14 | 68 | |
| 15 | 1 | |
| 16 | 3 | |
| 17 | 4 | |
| 18 | 27 | |
| 19 | 44 | |
| 20 | 51 |
About Kevin Litchfield
Kevin Litchfield is a scholar working on Cancer Research, Oncology and Immunology, having authored 53 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Cancer Genomics and Diagnostics (16 papers) and Testicular diseases and treatments (14 papers). The work is most often cited by research in Cancer Research (585 citations), Oncology (885 citations) and Immunology (458 citations). Kevin Litchfield has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Charles Swanton, Clare Turnbull, Samra Turajlic, Roberto Vendramin, Richard S. Houlston, Sergio A. Quezada, James L. Reading, James Larkin, Hang Xu and Yien Ning Sophia Wong. Their work appears in journals such as Nature, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.